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A. Abstract  19 
 20 
B. Objectives: This study aimed to explore the extent to which self-conscious emotions are 21 
expressed, to explore any associations with adverse health outcomes and to compare self-22 
conscious emotions in individuals with COPD to healthy controls.  23 
B. Methods: A two stage mixed-methods study design was employed. Interviews with 15 24 
individuals with COPD informed the choice of questionnaires to assess self-conscious 25 
emotions which were completed by individuals with COPD and healthy controls. 26 
B. Results: Five overarching themes were abstracted: grief, spectrum of blame, concern 27 
about the view of others, concealment and worry about the future. The questionnaires were 28 
completed by 70 patients [mean(SD) age70.8(9.4) years, FEV1%pred 40.5(18.8), 44%male] 29 
and 61 healthy controls [mean(SD) age62.2(12.9) years, 34%male]. Self-conscious 30 
emotions were associated with reduced mastery, heightened emotions and elevated anxiety 31 
and depression (all p<0.001). Individuals with COPD reported lower self-compassion, 32 
higher shame and less pride than healthy controls (all p≤0.01). 33 
B. Conclusion: There is a need to increase awareness of self-conscious emotions in 34 
individuals with COPD. Therapies to target such emotions may improve mastery, emotions 35 
and psychological symptoms 36 
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A. Introduction 40 
 41 
Symptoms of breathlessness on exertion limit the ability of individuals with Chronic 42 
Obstructive Pulmonary Disease (COPD) to sustain physical and social activities which are 43 
important for wellbeing, compromising quality of life and leading to psychological co-44 
morbidities 1-3. Personal culpability for COPD is often experienced due to the onset of the 45 
disease being commonly attributed to smoking behavior, potentially leading to self-46 
conscious emotions. 47 
 48 
Self-conscious emotions related to our sense of self and self-worth, are associated with both 49 
self-perceptions and appraisals of how we are perceived by others, and encompass feelings 50 
such as; guilt, shame, embarrassment and self-blame. In individuals with COPD such 51 
feelings of self-worth may be compromised by the presence of a chronic, debilitating 52 
disease which requires seeking help from family members 4. Visible differences conferred 53 
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by symptoms as well as dependency on others and on devices may force patients to 54 
reappraise their identity within the context of their disease 5.  55 
 56 
Constructions of self-blame and personal culpability for disease are prominent in narratives 57 
of patients with COPD 6-8. This is perhaps unsurprising if communicated by the substantial 58 
proportion of physicians who believe that patients with COPD are to blame for their disease 59 
(9). The experience of self-blame and concern about the manner in which others view their 60 
behavior has been associated with negative emotional responses including feeling shamed, 61 
disgraced, depressed and embarrassed, leading to reduced help-seeking, reduced adherence 62 
to oxygen therapy, failure to attend pulmonary rehabilitation (PR) and social isolation 6, 10-63 
12.  64 
 65 
To date, such issues have been noted indirectly, elicited from patients’ narratives describing 66 
their disease experience or exploring views on smoking behavior 6, 8. We chose to adopt a 67 
mixed-methods approach consisting of qualitative and quantitative methodologies to 68 
explore the extent to which self-conscious emotions are expressed in patients with COPD, 69 
to explore any associations with reduced health related quality of life (HRQOL), self-70 
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efficacy or increased psychological symptoms and to compare self-conscious emotions in 71 
individuals with COPD to healthy controls.   72 
 73 
A. Methods 74 
 75 
B. Study design  76 
A two stage mixed-methods study design was employed. Qualitative techniques enable the 77 
collection of detailed data allowing for true meaning and contradictions to be explored. 78 
Information arising from the qualitative phase informed the choice of questionnaires to 79 
assess self-conscious emotions which are relevant to individuals with COPD.  80 
 81 
Ethical approval for this study was obtained from the The Joint Bridgepoint Health – West 82 
Park Healthcare Centre – Toronto Central Community Care Access Centre – Toronto Grace 83 
Health Centre Research Ethics Board and all participants provided written informed 84 
consent prior to inclusion in the study. 85 
 86 
B. Recruitment  87 
C. Individuals with COPD 88 
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Eligible patients had a diagnosis of COPD confirmed by spirometry, a smoking history 89 
greater than 10 pack years, resided in the community and were able to provide written 90 
informed consent. Individuals were excluded if they had a primary respiratory diagnosis 91 
other than COPD and an inability to communicate because of language skills, hearing or 92 
cognitive impairment. Consecutive patients with COPD were approached in an out-patient 93 
respiratory clinic held at a specialized rehabilitation center.  94 
 95 
C. Healthy Controls 96 
Multiple strategies were used for the recruitment of healthy controls. Friends and family 97 
members of patients who attended respiratory clinics were approached. Posters, emails, 98 
advertisements, and announcements were displayed at the rehabilitation center. 99 
To be considered eligible controls had to; consider themselves ‘healthy’ and be over 40 100 
years old. Subjects were excluded if they had a chronic respiratory condition.   101 
 102 
B. Data collection 103 
C. Phase 1: Qualitative phase 104 
A semi-structured interview schedule consisting of open-ended questions was informed by 105 
the results of a previous study exploring the views of patients who refused a referral to PR 106 
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following an acute exacerbation 12. Feedback was provided from a patient advisory group 107 
consisting of four members. The interview schedule was revised throughout data collection.  108 
 109 
SH interviewed participants individually in a quiet room at the healthcare center. Interviews 110 
lasted between 20 minutes and 60 minutes and were largely patient led 111 
 112 
C. Phase 2: Quantitative phase 113 
Patients completed a questionnaire pack consisting of self-reported measures of self-114 
conscious emotions, COPD-specific items of self-consciousness, HRQOL, self-efficacy and 115 
psychological symptoms. The choice of measures was informed by the qualitative findings 116 
and advice was sought from a patient advisory group consisting of four individuals with 117 
COPD. Healthy controls completed a questionnaire pack consisting of the three measures 118 
of self-consciousness only.  119 
 120 
C. The Brief Fear of Negative Evaluation Scale 13  121 
The Brief Fear Negative Evaluation (BFNE) scale is a valid and reliable measure of social 122 
anxiety (α = 0.97) 14. It is convenient for use consisting of 12 items measured on a five-123 
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point likert scale (one to five). Scores range from 12 to 60 with higher scores indicating 124 
greater apprehension about others evaluations.  125 
 126 
C. The Shame and Guilt Scale 15 127 
The State Shame and Guilt Scale (SGS) contains five shame items (α = 0.89) five guilt 128 
items (α = 0.82) and five pride items (α = 0.78). Responses are given on a five-point Likert 129 
scale (1 = “always feeling this way” to 5 = “never feeling this way”). Lower scores indicate 130 
increased feelings of shame and guilt and elevated levels of pride. The scale was adapted to 131 
ask how individuals had felt “in the past two weeks” rather than at the present moment to 132 
counteract any influence of the hospital setting on levels of shame or guilt.  133 
 134 
C. The Self-Compassion Scale-Short Form 16  135 
The Self-Compassion Scale-Short Form (SCS-SF) assesses six aspects of self-compassion; 136 
self-kindness, self-judgment, common humanity, isolation, mindfulness, and over-137 
identification. The 12-items are rated on a five-point response scale ranging from one 138 
(almost never) to five (almost always). The shortened scale correlates well with the full 139 
SCS (r ≥0.97) 17. The total score is calculated by adding together each item and dividing by 140 
12.  141 
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C. COPD-specific items of self-consciousness Supplement 1 142 
Based on the qualitative findings and the advice from patient advisory group members 143 
disease-specific items were developed encompassing self-conscious emotions related to 144 
COPD. Each item is scored on a five-point Likert scale. Positive and negative statements 145 
were included so as not to induce feeling of self-consciousness.  146 
 147 
C. Health-related quality of life - The Chronic Respiratory Questionnaire-Self Reported 148 
(CRQ-SR) 18 149 
The CRQ-SR is a self-reported measure of health status shown to be valid and reliable in 150 
patients with COPD 19. It consists of four dimensions: dyspnoea, fatigue, emotion and 151 
mastery. 152 
 153 
C. Self-efficacy - The Pulmonary Rehabilitation Adapted Index of Self-efficacy (PRAISE) 20  154 
The PRAISE has been fully validated in a PR population 20. The tool consists of 15 155 
questions, each one scored from one to four with four being the highest level of perceived 156 
self-efficacy.  157 
 158 
C. Psychological symptoms - The Hospital Anxiety and Depression Scale (HADS) 21 159 
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The HADS comprises of two subscales; anxiety (α=0.68) and depression (α=0.91) with a 160 
score range of zero to 21. Scores ≥11 for each sub-scale are considered to indicate clinical 161 
caseness 21.  162 
 163 
B. Data analysis 164 
C. Phase 1: Qualitative phase 165 
All interviews were recorded and transcribed verbatim. The data was stored and organized 166 
using a computer software program (QSR NVivo version 9; QSR International, Doncaster, 167 
Australia) and analyzed using Inductive Thematic Analysis (ITA).  168 
 169 
The process of analysis followed the procedure described by Hayes (2000) 22 with 170 
researcher (SH) initially reading the transcripts to identify meaningful units of text. Initial 171 
coding for each transcript involved grouping units of text dealing with similar issues into 172 
categories and labeling them with a provisional name and definition, this step was 173 
undertaken by SH and verified in two transcripts by a second researcher (DB). SH and DB 174 
then systematically reviewed the original transcripts to ensure the labels and description 175 
assigned to each code were accurately supported by the data. Categories were grouped into 176 
emerging themes agreed on by the two researchers (SH, DB) and presented to members of 177 
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the patient advisory group and at a collaborative workshop consisting of; a research 178 
assistant, a nurse, an occupational therapist, a physiotherapist, two respirologists, two 179 
scientists, one PhD student and one clinical care coordinator. The final master themes were 180 
settled by SH and DB and thematic mapping was used to develop the relationships between 181 
themes.  182 
 183 
C. Phase 2: Quantitative phase 184 
The sample was powered to detect a medium effect size (0.30) for a positive/one-sided 185 
correlation 23.  186 
 187 
The statistical analyses were performed using SPSS® (Statistical Package for Social 188 
Sciences, version 18.0 for Windows). Relationships between self-reported measures of self-189 
consciousness and the COPD-specific items of self-consciousness and other variables were 190 
assessed using Pearson correlations. Due to multiple comparisons a Bonferroni correction 191 
was applied and the significance level was set at p<0.001. Comparisons between measures 192 
of self-consciousness in patients with COPD and healthy controls were performed using 193 
independent t-test with significance set at p<0.05. 194 
 195 
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 196 
A. Results 197 
B. Phase 1: Qualitative phase 198 
Fifteen individuals agreed to participate in semi-structured interviews. Demographic 199 
information was recorded and is displayed in table 1. Their mean age was 73 years, BMI 200 
24.7, FEV1%pred 41.1% and FEV1/FVC 44.2%. 201 
 202 
Across the five themes novel interpretations are described in detail, informed and 203 
contextualized by findings from the previous qualitative investigations. A total of five 204 
themes were identified. 205 
 206 
C. 1. Grief and loss 207 
Issues surrounding feelings of grief appeared two-fold: patients expressed grief for the 208 
person they once were and the things they used to be able to do and they articulated a sense 209 
of loss surrounding their inability to fulfill plans they had made for the future.  210 
 211 
Patients appeared acutely aware of the constraints on daily activities conferred by their 212 
disease, using strong language to portray the value placed on those activities in which they 213 
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were no-longer able to participate and consequent feelings of sadness and frustration “I 214 
love going out to get my wife but I won’t be driving anymore cause I’ve given up my 215 
license.” (ID. 1) “And I do miss not gardening. That is my biggest horror… that I can’t get 216 
and dig in the dirt.” (ID. 8). 217 
 218 
Participants’ transcripts relay accounts of the time and energy spent working to save for 219 
retirement and the anticipation of being unable to attain their goals. The excitement of 220 
fulfilling these plans appears to compound the sense of loss felt that due to the limitations 221 
inflicted by the progression of their disease they were no-longer able to complete” I wanted 222 
to start an indoor herb garden. That didn’t happen.”(ID. 2).  223 
 224 
C. 2. Spectrum of blame 225 
Blame was discussed by most participants as they made sense of their state of health and its 226 
origins and could be construed as a spectrum extending from personal culpability for the 227 
development of a chronic and progressive disease to fault from external agencies. 228 
 229 
At one end of the spectrum, five individuals readily accepted personal responsibility for 230 
their condition “Stupidity. There’s only uh two ways you can get emphysema, smoking and 231 
14 
 
second hand smoke” (ID. 13) and emphasized their compliance with interventions such as, 232 
PR and smoking cessation. At polar opposite three participants refused to accept any 233 
personal responsibility for their condition, ascribing their condition to occupational factors 234 
and passive smoking “I really do believe that it is the ceramic dust that has caused it.” (ID. 235 
10).  236 
 237 
For those patients expressing personal culpability for COPD dissonance appeared 238 
prominent alongside attempts to suppress thoughts or externalize blame. “Hitler’s fault.  239 
It’s a poor excuse but everybody smoked in the war.”(ID. 11). These narratives were 240 
infused with considerable emotional expressions of; shame, self-pity and regret. “I was full 241 
of self-pity and I was very depressed….Oh God, you think to yourself, you know, like you 242 
should have had a bag put over your head for being so unintelligent. You know?” (ID. 3), 243 
“I’m embarrassed to say that I was a smoker.” (ID. 5). 244 
 245 
C. 3. Concern about the view of others 246 
Participants’ narratives reflect heightened sensitivity to the ways in which they are viewed 247 
by others. Concerns were expressed surrounding the ‘visibility’ of the condition with 248 
subsequent impact on patients’ sense of wellbeing and adherence to supportive aids.  249 
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 250 
COPD seemed to be construed as a socially undesirable condition in terms of the symptoms 251 
it provokes “I mean the only thing that bothers me as far as other people go [cough] is my 252 
coughing. That can sort of embarrass me. Other than that…It’s gross.”(ID. 6) as well as its 253 
impact on physical appearance “It’s disgusting. I don’t like the bruises. Yeah it looks 254 
terrible, yeah.”(ID. 4).  255 
 256 
Patients’ appeared apprehensive about others evaluation “I’m sure when I get out of a car, 257 
people must look at me and think, why is she in handicap parking?” (ID. 6) “one thing I’m 258 
told is… should not swallow it. But yet if you’re in a public place what are you supposed to 259 
do?” (ID. 13) displaying an acute awareness of the manner in which they must appear and 260 
be perceived by others.  261 
 262 
Devices which increase the visibility of the disease, namely oxygen and rollers, were 263 
described as symbols of disability and aging provoking stoical attitudes. “Because you 264 
know I always associated it [rollator] with people who are feeble or old.”(ID. 15). 265 
Consequently, participants made attempt to minimize their dependency on aids to preserve 266 
an image of independence. “I don’t like using it [rollator]. Like I’ve never used it … when 267 
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I’ve gone anywhere.  Uh that … that maybe it’s uh… that might be a pride thing, I don’t 268 
know.” (ID. 6).  269 
 270 
Participants noted that even the most facilitative and well-intentioned actions were affected 271 
by their use of supports. Behavior could be a source of embarrassment and shame 272 
surrounding a sense of perceived vulnerability and burdening others. “I was coming home 273 
by bus.  And I felt too embarrassed to be in there because I was there... people got up and 274 
made sure I had a seat, that was… you know, but I felt as if it [rollator] was in the way. 275 
And I felt very embarrassed.” (ID. 10).  276 
 277 
Yet, other participants expressed gratitude for devices which improved function and 278 
enabled independence. “Uh, what the first time I was on oxygen?… I felt great. Yeah 279 
because uh… I was struggling all the time. And now I was struggling less.  Right?  And not 280 
all the time.” (ID. 14 ) “So I traded it [rollator] and got this one and ... … I couldn’t care 281 
less.  That’s how I get out, that’s how I get out.”(ID. 11). For these patients the benefits 282 
obtained through the use of these supportive devices appeared to outweigh any self-283 
conscious emotions. 284 
 285 
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C. 4. Concealment 286 
Participants describe attempts to hide their disability often driven by expressed guilt for 287 
contributing to their condition, and their motivation to retain integrity and appear physically 288 
robust. This desire to appear competent seems to overwhelm the need for their disability to 289 
be understood by others.  290 
 291 
Stoical attitudes are expressed, encouraged by feelings of guilt pertaining to the emotional 292 
burden patients see as inflicting on others. “I don’t really talk to … about it too much. I 293 
don’t volunteer any information. I try not to say anything to him about it.  Just let him know 294 
everything is fine, you know” (ID. 4).  295 
 296 
Participants attempts to conceal their condition seems driven by a desire to appear 297 
competent in their current roles, at work and in the home “I didn’t tell the truth, I never told 298 
a soul at work…..I had to present myself as someone who is extremely capable and keep 299 
trucking. I had to prove to yourself and everybody else that there was nothing wrong with 300 
me.”(ID. 3). Inability to complete these roles appeared to provoke shame-based emotions 301 
and diminished self-worth “Well I have become pretty useless.  Uh, you know it’s like when 302 
you can’t bend down to pick something up.” (ID 13). 303 
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Whilst hiding their condition permitted patients to maintain their identity and sense of self-304 
worth, frustration was expressed at the lack of awareness and compassion shown by others 305 
“it’s not a nice disease and it’s hidden too, so a lot of people don’t know you are sick 306 
and… … going up the stair I’ll stop at the mall and they… they try to push you out of the 307 
way” (ID. 4)  308 
 309 
Concealment seemed accompanied by social comparisons to others with COPD which 310 
served to minimize the significance of their own disease state. “So other people may have 311 
something.  There are some people there that are really ill.”(ID 9). Patients readily 312 
accepted delays in their care, emphasizing the urgency of attending to other patients’ needs 313 
before their own, believing their own condition to be less serious and or/life threatening and 314 
being unable or unwilling to assert themselves. “I would think they would deal with the 315 
heart attack and stroke before me. Would think it’s a bit more serious, whereas with me I 316 
would expect I guess, me being me, they could always give me a mask temporarily.” (ID. 317 
7). 318 
 319 
 320 
 321 
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C. 5. Worry about the future 322 
Patients’ narratives portrayed a sense of threat which was both imminent and yet stretched 323 
into the future. 324 
 325 
Patients appeared hyper-vigilant to their disease state voicing catastrophic cognitions 326 
concerning the effects of certain actions and activities “I get a little anxious especially 327 
when I am going home….I get anxious, my heart starts racing cause I realize okay… 328 
especially in the winter.  Put on a coat, put on the boots… even if it’s summer I guess.” (ID. 329 
15). Such anxieties appeared to result in avoidance of activities for fear that it would 330 
prompt undesirable symptoms “If the situation required me to exert a lot. I wouldn’t do 331 
it.”(ID. 7). 332 
 333 
The progressive nature of the disease seemed to provoke feelings of worry and uncertainty 334 
about what the future will hold “where is this going?  You know what I mean?  How bad is 335 
it going to get or how worse it’s going to get.” (ID. 5). Such concerns appeared to limit 336 
individuals’ ability to be spontaneous and live the lifestyle once known “Yep, it still affects 337 
my confidence because I travelled.  And uh … I had fears of not being able to get myself 338 
from point A to point B due to my limitations.” (ID. 3) 339 
20 
 
B. Phase 2: Quantitative phase 340 
C. Individuals with COPD 341 
Recruitment and patient demographics are reported in figure 1 and table 2 respectively 342 
 343 
C. Healthy controls 344 
Sixty three healthy individuals agreed to participate. Two were excluded from the data 345 
analysis because they had abnormal spirometry (Forced Expiratory Volume in one second 346 
(FEV1%) predicted <80% or Forced Expiratory Volume in one second/Forced Vital 347 
Capacity (FEV1/FVC) <70%) leaving 61 subjects to complete the questionnaires. Five 348 
subjects were unable to perform the spirometry testing correctly but were included on the 349 
basis they had no history of smoking or respiratory compromise. Subject characteristics 350 
(n=61) are displayed in table 2.  351 
 352 
B. Associations with health outcomes 353 
Self-reported measures of self-consciousness, including the COPD-specific items of self-354 
consciousness, correlated with each other (all p<0.01). Relationships between measures of 355 
self-consciousness and the COPD-specific items of self-consciousness with health 356 
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outcomes, including HRQOL, self-efficacy, anxiety and depression, are displayed in table 357 
3.  358 
 359 
B. Self-conscious emotions in individuals with COPD and healthy controls  360 
Differences between scores obtained on measures of self-conscious emotions in individuals 361 
with COPD compared to healthy controls are displayed in table 4. 362 
 363 
A. Discussion 364 
 365 
COPD is acknowledged as self-inflicted provoking painful emotions surrounding feelings 366 
of self-blame, embarrassment, shame and guilt. Self-conscious emotions were prominent 367 
and associated with reduced mastery, heightened emotions and elevated symptoms of 368 
anxiety and depression. Individuals with COPD were noted to be less compassionate 369 
towards themselves, have higher levels of shame and lower levels of pride than healthy 370 
controls.  371 
 372 
These findings echo previous literature in which self-blame and personal culpability are 373 
prominent in the narratives of individuals with COPD 6-8. Self-blame has been associated 374 
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with negative emotional responses including feeling shamed, disgraced, depressed and 375 
embarrassed, leading to reduced help-seeking, reduced adherence to oxygen therapy and 376 
social isolation 6,10,11. Self-conscious emotions are also reported in conjunction with 377 
negative feelings of dependency on people and on devices which force patients to 378 
reappraise their identity within the context of their disease. Such critical self-appraisals 379 
negatively influences self-confidence and challenges feelings of self-worth 5 which can lead 380 
to the decline of active interventions as patients feel undeserving of dedicated care 12. 381 
Feelings of worthlessness may also mean patients have difficulty asserting themselves. 382 
They describe feeling they have no right to complain especially when dealing with health 383 
care professionals 5. Shaming attributes may arise from interactions with health care 384 
professionals, who believe patients with COPD are to blame for their disease, resulting in 385 
patients feeling stigmatized 7,9. Therefore, health care professionals need to be mindful of 386 
interactions with patients; taking the time to listen can positively influence patients’ self-387 
control and feelings of self-worth 24. 388 
 389 
Self-conscious emotions have not previously been assessed objectively in individuals with 390 
COPD. Such emotions were strongly associated with reduced mastery, a heightened 391 
emotional response and elevated symptoms of anxiety and depression, detectable both by 392 
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the general measures of self-consciousness and the disease-specific items. This is the first 393 
study to apply these objective measures of self-compassion, shame and guilt to a population 394 
of older adults living with chronic disease. Patients with COPD were found to be less 395 
compassionate towards themselves than healthy controls of a similar age, and both 396 
populations in this study scored lower than scores reported in younger adults aged 17-36 397 
years 16.  398 
 399 
The vast majority of patients expressed feelings of guilt during the interviews and identified 400 
their “own behavior” as being responsible for their lung disease, yet questionnaire-assessed 401 
guilt did not differ between healthy individuals and those with COPD. Given that guilt is 402 
rarely experienced on the conscious level it may be difficult to detect using self-reported 403 
measures 25. Although it has been reported in the narratives of individuals newly diagnosed 404 
with COPD 26, it is unclear whether feelings of guilt remain salient eight years following 405 
diagnosis.  406 
 407 
This study is not without its limitations. The infrequent application of the self-conscious 408 
measures in those with COPD, in particular the SGS, makes it difficult to contextualize our 409 
results in comparison with other chronic disease populations. This measure was chosen as it 410 
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considers three important dimensions, (shame, guilt and pride) two of which (shame and 411 
pride) are strongly associated with important health outcomes. Given the number of 412 
correlations the chance of significant correlation was high. However, even after correction 413 
for multiple correlations all self-conscious emotions, with the exception of guilt, were 414 
significantly associated with reduced mastery, a heightened emotional response and 415 
psychological symptoms.  416 
 417 
Our observations suggest a need to scope and address self-conscious emotions in 418 
individuals with COPD. Therapies to target self-conscious emotions include, compassion 419 
focused therapy 27 and mindfulness 28. Self-compassion, as a key component of 420 
mindfulness, has been reported to mediate the effect of mindfulness-based cognitive 421 
therapy for depression supporting Gilberts’ model (2010) of self-compassion as a mediator 422 
for psychological affect 29, 20. A pilot randomized controlled trial of an eight week Mindful 423 
Self-Compassion program noted significant differences in favor of the intervention group in 424 
self-compassion, mindfulness, life satisfaction, depression, anxiety, stress and avoidance 425 
and these benefits were also visible after 12 months 31. Such interventions have the 426 
potential to improve wellbeing, reduce psychological symptoms and encourage effective 427 
disease strategies. Although disease-specific self-conscious items still require psychometric 428 
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testing prior to broader application in the COPD population, the items correlated well with 429 
other general measures of self-consciousness and with important health outcomes. They 430 
were simple to apply and well accepted by individuals with COPD.  431 
 432 
B. Conclusion 433 
Patient narratives reflected low levels of self-compassion, high self-judgment and 434 
diminished self-worth, known to negatively impact on help-seeking behavior and adherence 435 
to active interventions. Self-conscious emotions are prominent and were associated with 436 
reduced mastery, heightened emotions and elevated symptoms of anxiety and depression. 437 
Individuals with COPD were less compassionate towards themselves, had higher levels of 438 
shame and lower levels of pride compared with than healthy controls of a similar age. An 439 
improved awareness of self-conscious emotions will enable targeted therapy aimed at 440 
improving mastery and reducing psychological symptoms. 441 
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Table 1. Patient demographics for Phase 1: Qualitative phase 545 
 546 
 547 
 548 
 Age (y) Gender BMI FEV1%pred FEV1/FVC Smoking 
status 
Pack 
years 
Length of 
diagnosis (y) 
Social status 
(lives with) 
Oxygen 
usage 
Walking 
aid usage 
ID. 1 72 M 19.7 29 29 Ex 50 11 Alone Yes Yes 
ID. 2 70 F 21.3 23 37 Ex 15 8 Spouse No Yes 
ID. 3 66 F 20.9 25 42 Ex 10 28 Spouse Yes Yes 
ID. 4 63 M 35.4 30 42 Ex 60 16 Alone No Yes 
ID. 5 78 F 23.8 45 50 Ex 20 16 Alone No Yes 
ID. 6  68 M 25.9 29 30 Ex 100 4 Alone No No 
ID. 7 69 F 20.7 45 27 Ex 40 10 Spouse No Yes 
ID. 8 90 F 30.0 66 68 Yes 60 14 Alone Yes Yes 
ID. 9 85 M 30.1 59 51 Ex 95 18 Alone No No 
ID. 10 76 F 32.1 48 73 Ex 20 17 Alone No Yes 
ID. 11 76 F 23.0 50 58 Ex 50 10 Alone No Yes 
ID. 12 73 F 27.2 50 30 Ex 40 4 Alone Yes Yes 
ID. 13 72 M 21.5 56 49 Ex 58 24 Spouse Yes Yes 
ID. 14 65 M 22.2 31 47 Yes 100 20 Alone Yes Yes 
ID. 15 68 F 16.9 30 30 Ex 40 21 Spouse No Yes 
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Table 2. Between group differences in characteristics between individuals with COPD and healthy controls 549 
 550 
 551 
 Individuals with COPD (n=70) 
Mean (SD) 
Healthy controls (n=61) 
Mean (SD) 
Between group differences 
Age (y) 70.8 (9.4) 66.2 (12.9) p=0.33 
Gender (%male) 44 34 p=0.23 
BMI 25.2 (6.3) 25.8 (4.9) p=0.617 
FEV1%pr 40.5 (18.8) 89.2 (28.0) p<0.001 
FEV1/FVC 43.5 (14.4) 76.4 (7.5) p<0.001 
Smoking status (%yes, ex, no) 5.7  
94.3  
0 
4.9  
18.0 
77.0 
 
 
p<0.001 
Pack years 43.5 (21.7) 2.8 (7.3) p<0.001 
Length of diagnosis (y) 8.8 (6.7)   
Number of co-morbidities 2.7 (2.0) 1.1 (1.4) p<0.001 
Social status (lives with) (%alone 
spouse, family, other) 
37.7 
37.1 
24.3 
1.4 
28.3 
58.3 
10.0 
3.3 
 
 
p=0.004 
Oxygen usage (% yes) 44.3   
Walking aid usage (% yes) 51.4   
SD; Standard Deviation, BMI; Body Mass Index, FEV1; Forced Expiratory Volume in one second FEV1/FVC; Forced 
Expiratory Volume in one second/Forced Vital Capacity 
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 552 
 CRQ-SR: 
Dyspnoea 
CRQ-SR: 
Fatigue 
CRQ-SR: 
Mastery 
CRQ-SR: 
Emotions 
PRAISE HADS: Anxiety HADS: 
Depression 
BFNE NS NS r=-0.47* r=-0.60* NS r=0.60 * r=0.49* 
SCS-SF 16 NS NS r=0.41* r=0.55* NS r=-0.50* r=-0.51* 
SGS: Guilt NS NS NS r=0.45* NS r=-0.47* NS 
SGS: Shame NS NS r=0.52* r=0.65* NS r=-0.70* r=-0.56* 
SGS: Pride NS NS r=-0.50* r=-0.57* NS r=0.58* r=0.61* 
COPD-specific items 
of self-consciousness 
NS NS r=0.58* r=0.65* NS r=-0.51* r=-0.55* 
 553 
 554 
 555 
 556 
 557 
 558 
 559 
 560 
 561 
Table 3: Significant correlations between self-conscious emotions and health related quality of life (HRQOL), self-efficacy and 
psychological symptoms (Persons r) 
BFNE: Brief Fear of Negative Evaluation, SCS-SF: Self-Compassion Scale-Short Form, SGS: Adapted Shame and Guilt Scale, COPD: Chronic 
Obstructive Pulmonary Disease, PRAISE: Pulmonary Rehabilitation Adapted Index of Self-Efficacy, HADS: Hospital Anxiety and Depression 
Scale, CRQ-SR: Chronic Respiratory Questionnaire-Self-Reported.  
Due to multiple comparisons significance levels were set at p<0.001* 
NS: Not Significant 
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 562 
 563 
 564 
 565 
 566 
 567 
 568 
 569 
 570 
 571 
 572 
 573 
 574 
 575 
 576 
 577 
 578 
 579 
 580 
 581 
 582 
 583 
 584 
 585 
 586 
 587 
 588 
 589 
 590 
 591 
 592 
 593 
 594 
Measures of self-
conscious emotions 
COPD (n=70) 
mean (SD) 
Healthy controls 
(n=59) 
mean (SD) 
Between-group 
differences 
BFNE 27.8  (10.5) 30.9 (7.2) p=0.046* 
SCS-SF 3.3 (0.6) 3.6 (0.7) p=0.010* 
SGS - Guilt 18.8 (4.3) 18.6 (3.4) p=0.808 
SGS - Shame 21.3 (3.9) 23.0 (2.8) p=0.006* 
SGS - Pride 12.3 (4.03) 10.3 (3.2) p=0.001* 
Table 4. Self-conscious emotions in individuals with COPD compared to healthy 
controls 
COPD: Chronic Obstructive Pulmonary Disease; SD: standard deviation; BFNE: Brief Fear of 
Negative Evaluation, SCS-SF: Self-Compassion Scale-Short Form, SGS: Adapted Shame and 
Guilt Scale 
Significance levels were set at p<0.05* 
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Figure 1: Recruitment diagram for Phase 2: Quantitative Phase, individuals with COPD 595 
 596 
Screened for 
eligibility n=142 
Enrolled n=75 
Excluded n=23 
Palliative/too unwell n=2 
< 10 pack years n=1 
Admitted to inpatient hospital n=8 
Long term healthcare center n=1 
Cognitive impairment n=5 
Limited/no English n=6 
Completed n=70 
Refused n=45 
Reasons included; not having 
enough time to complete the 
questionnaires, not being interested 
in research, feeling too unwell, one 
patient did not want to discuss 
emotional issues.  
Dropped out n=4 
Failed to return the questionnaire or 
did not attend scheduled 
appointment. 
